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ZUSAMMENFASSUNG 
 
Transposons sind genetische Elemente, die fähig sind, sich innerhalb des Genoms 
zu bewegen. Obwohl Transposons lange Zeit als parasitäre Elemente oder gar 
molekularer Müll galten, erfahren sie seit einiger Zeit Anerkennung als Werkzeu-
ge für unterschiedliche genetische Anwendungen. Sleeping Beauty (SB) gehört 
zur Tc1/mariner-Superfamilie von Transposons. SB wurde aus molekularen Fossi-
lien rekonstruiert [Ivics, 1997], um u.a. einen sicheren und effizienten Vektor für 
die Gentherapie zu schaffen. Zu diesem Zweck ist es notwendig, den Mechanis-
mus der SB-Transposition und deren Regulation, die Aktivitäten des Proteins und 
den Einfluss von Wirtsfaktoren genau zu verstehen. Aus diesem Grund habe ich in 
meiner Arbeit die einzelnen Schritte des Transpositionsprozesses und die Bildung 
des sogenannten paired-end complex (PEC) – eine Voraussetzung für die folgen-
den katalytischen Reaktionen – untersucht. Zusätzlich habe ich versucht, einen in 
vitro Transpositionstest für SB zu etablieren. Ein solcher Test könnte der schnel-
len Untersuchung von Mechanismen dienen, die die Regulation der Transposition 
beeinflussen. 
SB gehört zur IR/DR-Gruppe der Tc1/mariner-Superfamilie von Transposons. Im 
Gegensatz zu mariner-like-Elementen mit kurzen inverted repeats (IR) ist die 
IR/DR-Struktur von SB durch lange IRs mit insgesamt vier Bindestellen für die 
Transposase gekennzeichnet. Ich habe die Fähigkeit dieser beiden Transposon-
Systeme zum Ausschneiden eines Transposonendes ohne die Beteiligung des an-
deren Endes im PEC getestet. Solche unpräzise Transposition kann zu genomic 
rearrangements führen. Meine Ergebnisse zeigen, dass SB zwar imstande ist, ein 
einzelnes Transposonende auszuschneiden, dies geschieht jedoch weit weniger 
effizient als bei mariner-like-Elementen. Die Unterdrückung unpräziser Transpo-
sitionsereignisse ist ein Ergebnis der besseren Regulation von SBs Transposition, 
die durch die IR/DR-Struktur bedingt ist. Die Komplexität der IRs in Kombinati-
on mit der zweiteiligen (PAIRED) DNA-Bindedomäne von SB kann als Mittel 
einer raffinierten Regulation des Transpositionsprozesses angesehen werden, wel-
che das Genom vor anormalen Transpositionsereignissen schützt. Die Ergebnisse 
meiner Arbeit legen ein Modell nahe, in dem die Bildung des PEC während der 
Transposition von SB ein höchst genau regulierter Prozess ist, der durch die 
DNA-Protein- und Protein-Protein-Bindeaffinitäten der beiden DNA-Binde-
Subdomänen geleitet wird. 
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ABSTRACT
 
Transposons are pieces of DNA able to move within the genomes. These mobile 
elements previously seen as “junk DNA” gained much interests recently as possi-
ble tools for various genetic applications. Sleeping Beauty is a verterbrate 
Tc1/mariner transposon reconstructed from molecular fossils [Ivics, 1997] to cre-
ate a safe and efficient vector for gene therapy. For that purpose it is important to 
deeply understand the mechanism and regulation of the SB transposition, the ac-
tivities of the transposase and influence of host factors on the process. Therefore, 
in this project I studied the single steps of the transposition reaction and formation 
of the paired-end complex (PEC) which is a prerequisite for the subsequent cata-
lytic steps. Additionally, I tried to establish an in vitro transposition assay for 
Sleeping Beauty that would serve an easy assay for testing the system and probe 
mechanisms affecting the regulation of transposition activity. 
Sleeping Beauty belongs to the IR/DR subfamily of the Tc1/mariner-like trans-
posons. In contrast to mariner-like elements with short inverted repeats (IR), the 
IR/DR structure of SB is characterized by long IRs with four binding sites for the 
transposase. I compared the ability of the two systems to perform cleavage of the 
single transposon end without including the second end in the PEC. Such impre-
cise transposition can lead to genome rearrangements. My results show that SB is 
capable of single-end cleavage; however, to much lower extent than the mariner-
like element. Lower number of imprecise transposition events is a result of better 
regulation of the SB transposition that might be imposed by the IR/DR stucture. 
The complexity of the inverted repeats together with the bipartite (PAIRED) 
DNA-binding domain of SB might offer means for more sophisticated regulation 
of the transposition process, thereby protecting the genome from aberrant transpo-
sition events. I propose that complex formation in SB transposition is a strictly 
regulated ordered assembly process, guided by DNA-protein and protein-protein 
interaction interfaces of the DNA-binding subdomains. Obtained results allowed 
me to draw a model how the paired-end complex is formed. 
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ABBREVIATIONS 
 
ATP adenosine triphosphate 
bp base pair 
C-/N-terminus carboxy-/amino-terminus 
cpm counts per minute 
DNA  desoxyribonucleic acid 
DR direct repeat 
E.coli Escherichia coli 
HMGB1 High-mobility group box 1 
HTH helix-turn-helix 
IHF integration host factor 
IR inverted repeat 
IS insertion sequence 
kb kilobase 
kD kilodalton 
LINE  long-terminal interspersed elements 
LTR Long Terminal Repeat 
M molar 
MBP maltose-binding protein 
min minute 
neo neomycin 
NLS nuclear localization signal 
OD optical density 
ORF open reading frame 
PCR polymerase chain reaction 
PEC paired-end complex 
RNA ribonucleic acid 
RNAi RNA interference 
SB Sleeping Beauty 
SINE  short interspersed elements 
TE transposable element 
wt wild type 
X-SCID X-linked severe combined immunodeficiency 
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1 INTRODUCTION
 
 
1.1 Transposable elements 
 
Transposable elements are pieces of DNA capable of moving from one place to 
another within the genome. First transposons were discovered in maize (Zea
mays) by Barbara McClintock in the 1940s [McClintock, 1950]. Studying the me-
chanisms of the mosaic colour patterns of maize seeds, she discovered that two 
genetic loci responsible for the mosaicism are able to change their positions on the 
chromosomes. She named the loci Dissociator (Ds) for causing the breakage of 
the chromosome 9 and Activator (Ac) whose presence was required for 
chromosome dissociation. 
Nowadays, we know that transposons are widespread in nature, present in bacte-
ria, invertebrates, vertebrates and plants. They constitute about 45% of the human 
genome [Lander, 2001]. Even though, for long time considered as useless “junk 
DNA”, studies showed that transposons have evolutionary impact and their pres-
ence has been found in ~4% of human protein-coding regions [Nekrutenko, 2001], 
[Volff, 2006]. Additionally, transposable elements gained much attention as possi-
ble tools for practical applications, e.g. gene therapy. 
Transposons relocate in a recombination process called transposition. Transposi-
tion is the recombination reaction that mediates movement of DNA segments be-
tween many nonhomologous sites. Because the transposable elements are mobile, 
they have the capacity to change host gene information, for example, by inserting 
into a gene and disrupting its coding sequence or by inserting adjacent to a gene 
and influencing its expression. Transposons play a very important role in evolu-
tion being a source of many genetic variations. 
Different types of the mobile elements have been identified and classified based 
on their structure and mechanism of transposition. There are two main classes of 
transposable elements depending on the intermediate used in the transposition 
reaction. Class I gathers elements utilizing RNA as the intermediate and thus 
called retroelements; class II elements use DNA as the transposition intermediate 
(Abb. 1). DNA transposons are common in bacteria, invertebrates and plants, 
whereas in vertebrates retrotransposons are more abundant [Henikoff, 1992]. 
Retroelements contain a reverse transcriptase gene and transpose duplicatively in 
a process called retroposition. The DNA element is transcribed to RNA, then re-
verse-transcribed to DNA, and integrated elsewhere in the genome. Retroelements 
are divided into two major groups depending on the presence or absence of Long 
Terminal Repeats (LTR). The non-LTR elements including short interspersed 
elements (SINE) and long-terminal interspersed elements (LINE) make up 33.9% 
of the human genome (reviewed in [Bannert, 2004]). The LTR class includes 
retrotransposons, endogenous retroviruses and group II introns. 
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Abb. 1: Classification of transposable elements. Transposable elements are grouped into 
two classes depending on the intermediate used in the transposition reaction. LTR-
retrotransposons have Long Terminal Repeats (LTR) flanking genes coding for gag (pro-
tein required for the assembly of the RNA transcript into cytoplasmic particles), protease 
(PR), integrase (IN) and reverse transcriptase (RT); LINEs (long-terminal interspersed 
elements) encode endonuclase (EN) and RT; SINEs (short interspersed elements) are 
derived from 7SL RNA and have no coding capacity; DNA-transposons consist of in-
verted repeats flanking gene encoding for the transposase; bacterial composite trans-
posons (here Tn10) carry antibiotic resistance gene (tetR) flanked by full-length insertion 
sequences (IS). 
 
Hundreds of DNA-transposons have been identified in bacteria. Several kinds of 
transposable elements can be distinguished, such as simple insertion sequences, 
composite transposons and bacteriophages. Majority of insertion sequences (IS) 
are composed of recombinationally active 10–40 bp short DNA sequences that 
define the ends of the element and flank an open reading frame encoding the 
transposase enzyme which recognizes and processes these ends. Based on simi-
larities in genetic organization and in transposase structure, ISs have been classi-
fied into 19 families. Members of the IS630 family show significant similarities 
with eukaryotic Tc1/mariner-like elements. Tn7 is an example of another type of 
bacterial transposons, that similarly to ISs has short inverted repeats, but in con-
trast to ISs it codes for a number of proteins, five transposition genes and two an-
tibiotic resistance genes [Rogers, 1986]. 
The third group consists of composite transposons, such as Tn5 and Tn10, which 
DNA region coding for antibiotic resistances is flanked by IS elements at both 
ends in opposite orientation [Berg, 1982], [Foster, 1981]. The transposase is en-
coded by the right IS and is able to mobilize the ISs alone as well as the complete 
element [Kleckner, 1996]. Mu is a bacteriophage that infects E.coli using DNA-
based transposition to integrate its genome into the genome of the host cell. It can 
then use transposition to initiate its viral DNA replication. Mu is a very complex 
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transposable element requiring for the process two Mu proteins, Mu A and Mu B, 
two host proteins, HU and IHF,[Krause, 1986], [Lavoie, 1993] and the presence of 
transpositional enhancer [Surette, 1989], [Chaconas, 1996]. Important feature of 
the Tn5 and Tn10 transposons and the Mu bacteriophage is the trans activity of 
the catalytic domain of the transposase. It means that the transposase bound to one 
transposon end process the cleavage of the second transposon end [Naumann, 
2000]. In such case, formation of the paired-end complex bringing two transposon 
arms together is strictly required for catalytic steps to take place. This trait might 
be also shared by other prokaryotic elements. 
The largest group of eukaryotic DNA-transposons is composed of members re-
lated to the mariner and the Tc1 families. 
 
 
1.2 Tc1/mariner family 
 
Members of the Tc1/mariner transposon family are found in eukaryotes ranging 
from insects and nematodes to fish and humans (reviewed in [Plasterk, 1999]. 
Tc1/mariner elements are about 1.3 to 2.4 kb in length and consist of a single 
gene encoding the transposase enzyme flanked by terminal inverted repeats (IRs). 
The IRs of different elements vary in length, but all of them contain sites recog-
nized and bound by the transposases. The transposase is the protein catalyzing the 
remobilization of the transposable element. The protein has an N-terminal DNA-
binding domain specifically recognizing the transposon DNA [Vos, 1994], 
[Colloms, 1994], [Wang, 1999], [Izsvak, 2002] and a C-terminal catalytic domain 
with a conserved DDE or DDD motif [Doak, 1994]. Transposase activity is suffi-
cient to mediate full transposition reaction in vitro [Vos, 1996], [Lampe, 1996]. 
Nevertheless, this evidence does not exclude the involvement of host proteins in
vivo. The sequence and length of the flanking inverted repeats are not conserved 
within the family, with the exception of the most terminal nucleotides (5’-CAGT) 
[Radice, 1994]. All Tc1/mariner elements insert exclusively into a TA dinucleo-
tide leading to duplication of the TA sequences [Plasterk, 1996]. 
The Tc1/mariner family can be divided into two subfamilies. The founding ele-
ment of the Tc1 family was initially detected in the C. elegans genome and was 
called Tc1 for transposon caenorhabditis number 1 [Emmons, 1983]. The first 
mariner subfamily member was identified in Drosophila mauritiana [Jacobson, 
1985]. Since then, many elements were found in various organisms, but only few 
are naturally active. Most Tc1/mariner transposons accumulated over the time 
inactivating mutations, frame shifts or small deletions resulting in nonfunctional 
elements. In vertebrates, not a single active element has been identified. However, 
several active elements have been reconstructed based on sequences of multiple 
dead copies. The first molecular reconstruction brought to life a fish element, 
called Sleeping Beauty [Ivics, 1997]. Sleeping Beauty was followed by Frog
Prince from frog species Rana pipiens [Miskey, 2003] and Himar1 from the horn 
fly Haematobia irritans [Lampe, 1996]. 
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1.3 Sleeping Beauty 
 
Isolation of an active element from vertebrates would open a way to develop 
transposon-based vectors for germline transformation and insertional mutagenesis 
in this group of animals. As the attempts to find an active element failed, a recon-
struction from molecular fossils has been undertaken. A member of the 
Tc1/mariner family was chosen, as the family seemed not to be as demanding for 
species-specific factors. 
Sleeping Beauty transposon system was reconstructed based on phylogenetic data 
collected from Tc1-like elements in different teleost fish species and comparative 
analysis of functional transposase domains [Ivics, 1997]. The SB transposon sys-
tem consists of two components: a synthetic gene encoding a transposase enzyme, 
and a nonautonomous salmonid-type element carrying the inverted repeats. This 
system is very similar to a transposon active approximately 10 million years ago 
[Ivics, 1996] that was able to invade a great number of teleost genomes. 
 
 
1.3.1 The SB transposon system (Abb. 2) 
 
1.3.1.1 Transposase
 
The SB transposase has an N-terminal bipartite DNA-binding domain [Vos, 1994] 
similar to the paired domain originally described in important developmental 
regulatory proteins in eukaryotes, such as the Pax family of transcription factors 
[Czerny, 1993], [Gehring, 1994], [Jun, 1996]. The DNA-binding domain consists 
of two helix-turn-helix motifs (HTH) called PAI and RED (PAI+RED = PAIRED 
domain). The PAI subdomain is responsible for the specific binding to the DNA 
binding sites [Izsvak, 2002]. The function of the second HTH (RED subdomain) 
has not been defined. As in all PAIRED-like domains, a GRPR-like motif (GRRR 
in SB) is located between the two HTH motifs [Gehring, 1994], [Izsvak, 2002]. It 
mediates interactions with DNA in the Hin invertase of Salmonella [Feng, 1994] 
and in the RAG1 recombinase of V(D)J recombination [Spanopoulou, 1996]. The 
RED subdomain overlaps partially with the nuclear localization signal (NLS). The 
NLS is flanked by a putative phosphorylation target sites of casein kinase II 
[Ivics, 1996]. Phosphorylation of these sites may play a role in the regulation of 
the transposition. 
Catalytic domain of the SB transposase responsible for the DNA cleavage and 
joining reactions is located in the C-terminus of the protein. It contains a DDE 
motif consisting of two aspartate (DD) and one glutamate (E) amino-acid resi-
dues. The DDE motif is conserved among transposases, integrases and recombi-
nases and is essential for catalytic activities. Closely related mariner transposases 
have a DDD triad and substitution of the third aspartatic residue with the gluta-
matic residue (DE) results in inactivation of the protein [Lohe, 1997]. Addition-
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ally, there is a glycine-rich region within the catalytic domain of the SB transpo-
sase. However, its function remains unknown. 
 
 
1.3.1.2 Transposon DNA 
 
Tc1-like elements, including SB, but not the Tc1 itself, have special organization 
of inverted repeats, termed IR/DR structure [Plasterk, 1999]. The inverted repeats 
(IR) are approximately 230 bp long and each contains two binding sites for the 
transposase. The binding sites are very similar in sequence and heading in the 
same direction, thus called direct repeats (DR). However, the DRs are not identi-
cal, showing 3 nucleotides differences in sequence and 2 nucleotides differences 
in length. The binding sites placed directly at the transposon ends are called outer 
DRs and the binding sites placed approximately 165 bp distantly from the cleav-
age sites are called inner DRs (Abb. 2B). All four binding sites within the IR/DR 
structure are required for SB transposition [Izsvák, 2000]. In contrast, for another 
Tc1-like element, Tc3, the internal binding sites play no major role in the transpo-
sition reaction, since deleting it does not affect the transposition frequency 
[Fischer, 1999]. Additionaly, the inverted repeat upstream of the SB transposase 
gene contains a transpositional enhancer-like sequence, termed HDR [Izsvak, 
2002]. 
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Abb. 2: The Sleeping Beauty transposon system. A. structure of the SB transposase con-
sisting of bipartite DNA-binding domain (PAI and RED), nuclear localization signal 
(NLS) and C-terminal catalytic domain; B. structure of the SB transposon DNA consist-
ing of two inverted repeats (IR). Each IR has two binding sites (DR) for the transposase 
(shown as yellow and green triangles); under the structure comparison of the sequences of 
inner and outer DR with differences highlighted in the grey boxes; C. in vivo transposi-
tion assay: cells are cotransfected with plasmid carrying the inverted repeats flanking a 
selection marker together with a transposase expressing plasmid or an unrelated gene as a 
negative control. The ratio between the numbers obtained in the presence versus the ab-
sence of transposase is the readout of the assay [Ivics, 1997]. 
 
An in vivo transposition assay was developed to check the ability of the two-
component SB system to undergo transposition [Ivics, 1997]. Plasmid with the 
reconstructed transposase gene and plasmid carrying the inverted repeats flanking 
a selection marker (neomycin-resistance) gene were cotransfected. When the 
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transposition takes place and the transposon is reinserted into the genome, the 
cells gain the resistance and grow under neomycin selection. The formed colonies 
are stained and counted. The ratio between the numbers obtained in the presence 
versus the absence of transposase is the readout of the assay, and is the measure of 
the efficiency of the transposition (Abb. 2C). The transposition assay was per-
formed in cells of different vertebrate classes: seven fish species, mouse, human, 
frog, quail, sheep, cow, dog, rabbit, hamster and monkey [Izsvák, 2000]. SB was 
able to increase the frequency of transgene integration in all of these cell lines, 
with the exception of the quail. These results indicated that SB is active in most 
vertebrate species what makes it a good tool for studying the biology of DNA-
transposons. 
 
 
1.3.2 The mechanism of SB transposition 
 
In 1994, a model was suggested for the chemical steps of Tc1/mariner transposi-
tion based on analysis of Tc3 transposition and on the analogy with other trans-
posable elements in prokaryotes and V(D)J recombination [van Luenen, 1994]. 
The model (shown in Abb. 3) is so called cut-and-paste mechanism. The transpo-
sition process can be essentially divided into four main steps: 1) binding of the 
transposase to the transposon DNA; 2) formation of a paired-end-complex; 3) 
excision from the donor site; 4) target capture and reintegration at a target site. 
Sleeping Beauty transposes via cut-and-paste mechanism. First, the SB transposase 
recognizes and binds four specific transposon sequences at the ends of the element 
(direct repeats, DR) what is followed by paired-end-complex (PEC) formation of 
transposase tetramer bringing two transposon ends in close proximity. Then, the 
transposase is able to make double-stranded DNA breaks at each end. The breaks 
occur by hydrolysis of the phosphodiester bond exactly at the 3’-end of the trans-
poson and three nucleotides within the transposon at the 5’-end. (for some trans-
posons the break at the 5’-end occurs two nucleotides from the terminus). Every 
DNA strand cleavage in transposition reaction is Mg2+-dependent. The element is 
released from the donor leaving behind 3-nucleotide-long 3’-overhangs at the ex-
cision site [Luo, 1998]. The excision site will be repaired by the host factors gen-
erating 3 bp footprints. The OH group at the 3’-ends of the excised transposon 
attacks the phosphodiester bond that flanks the TA target at the 3’-ends. The 
cleavage of the phosphodiester bonds at the target site is carried out in one step 
with the fusion to the 3’ ends of the incoming transposon. The integration occurs 
exclusively into TA dinucleotide [van Luenen, 1994], [Ivics, 1999], with a prefer-
ence for certain sequences flanking the TA dinucleotide. However, the target site 
selection is determined primarily on the level of DNA structure, and not by spe-
cific base-pair interactions [Vigdal, 2002]. Upon insertion a five-nucleotide sin-
gle-stranded gap at each transposon terminus is formed, that is thought to be re-
paired by host machinery. 
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1.3.3 Effects of host factors on SB transposition 
 
For Tc1, Himar1 and Mos1 an in vitro assay has been developed with the transpo-
sase as the only protein suggesting that these reactions do not require presence of 
other proteins [Vos, 1996], [Lampe, 1996], [Tosi, 2000]. However, some host pro-
teins may influence the efficiency of the transposition process. Indeed, for SB four 
host factors have been identified, HMGB1 [Zayed, 2003], Ku 70/80 [Izsvak, 
2004] and Miz-1 [Walisko, 2006]. Miz-1 is a Myc-associated transcription factor 
[Peukert, 1997] and a potent cell-cycle regulator [Staller, 2001]. Through its asso-
ciation with Miz-1, the SB transposase down-regulates cyclin D1 expression pro-
longing this way the G1 phase. A temporary G1 arrest enhances transposition 
[Walisko, 2006]. Ku 70/80 is a repair factor involved in repairing DNA damage 
produced by transposon excision. HMGB1 is an abundant, non-histone, nuclear 
protein associated with eukaryotic chromatin [Bustin, 1999]. The protein interacts 
with DNA in a sequence-independent manner, bending the DNA [Thomas, 2001]. 
HMGB1 was shown to interact with SB and to enhance preferential binding of the 
transposase to the inner direct repeat within the transposon inverted repeats as 
well as promote bending of DNA fragments comprising the transposon inverted 
repeats [Zayed, 2003]. 
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Abb. 3: Cut-and-paste mechanism of transposition. The transposition process can be 
essentially divided into four main steps: 1) binding of the transposase to the transposon 
DNA; 2) formation of a paired-end-complex (PEC); a tetramer of the transposase brings 
two transposon arms in close proximity; 3) excision from the donor site; 4) target capture 
and reintegration at a target site. Gaps at the excision and integration site are repaired by 
the host machinery. 
 
 
1.3.4 Possible applications of the SB transposon system 
 
Many new methods based on DNA transposons, retrotransposons, and even mo-
bile introns have become practical in vitro as well as in vivo, affording new levels 
of specificity and efficiency. However, until recently, transposons were used as 
tools only in invertebrate systems, as no active vertebrate transposon was avail-
able. Resurrection of the Sleeping Beauty brought to life a promising tool for vari-
ety of applications. As previously mentioned, SB shows activity in many different 
animals making it a good tool for insertional mutagenesis. The system is being 
developed in such model organisms as mice and rats to facilitate the gene function 
analysis [Mátés, 2007]. Transposon based mutagenesis has several advantages; the 
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rate of DNA integration into chromosomes is high and the insertion site can be 
easily identified. 
SB is a promising alternative to viral vectors for gene therapy. Vectors based on 
such viruses as retroviruses, lentiviruses, adeno-associated viruses have been de-
veloped and applied in gene therapy trials (reviewed in: [Kennedy, 1997], [Park, 
2008], [Goins, 2008]. However, preferential integration of viruses into transcrip-
tion units/genes [Schröder, 2002] together with strong enhancer/promoter ele-
ments in its long terminal repeats (LTRs) carry risks of undesired influence on 
expression of other, properly functioning, genes. Indeed, some of the patients with 
X-linked severe combined immunodeficiency (X-SCID) cured by gene therapeu-
tic approach with retroviral vector developed leukemia upon insertion of the vec-
tor in proximity to T-cell oncogene [Hacein-Bey-Abina, 2003]. In addition, there 
is always the fear that the viral vector, once inside the patient, may recover its 
ability to cause disease. SB system might be a safer alternative to viral vectors as 
it shows fairly random integration profile [Vigdal, 2002], integration target site 
selection for retroviruses and transposable elements reviewed in [Wu, 2004]. 
Moreover, SB exhibits benign enhancer/promoter activities that can be reduced by 
incorporation of insulators [Walisko, 2008]. Importantly, the transgene carried by 
the SB transposon integrates at high rate and shows long-term expression. Addi-
tionally, unpublished data from our laboratory indicate activity of the SB system 
not only in dividing but also in non-dividing cells. 
The Sleeping Beauty transposon system has proven efficacy in the treatment of 
hemophilia [Yant, 2000], tyrosinemia type I [Montini, 2002], junctional epidermo-
lysis bullosa [Ortiz-Urda, 2003] and type 1 diabetes [He, 2004] in mouse models 
for human genetic disorders. Moreover, methods have been developed to deliver 
Sleeping Beauty transposons to the lung, liver and tumors for treatments for cystic 
fibrosis, cardiovascular and metabolic diseases, and cancer (reviewed in [Essner, 
2005]. In the United States, the first clinical trials for cancer gene therapy using 
Sleeping Beauty system have been launched last year [Williams, 2008]. 
To improve the Sleeping Beauty system successful approach was undertaken in 
our laboratory to create more active enzyme [Mátés, 2009]. Additionally, fusion 
proteins of SB transposase with specific DNA binding domains are being devel-
oped to achieve targeted gene insertion [Voigt, 2008]. Deep understanding of the 
mechanism of SB transposition and its interactions with host environment would 
also contribute to improving the system in order to use it as a gene therapy vector. 
 
 
1.4 Regulation of transposition 
 
Mobilization of transposons must be under tight regulation, in both its frequency 
and insertional specificity, to avoid the accumulation of genome rearrangements 
that could be deleterious to the host. The level of transposition activity is probably 
the result of a balance between the interests of the transposable elements and those 
of the hosts they inhabit. Different host- and transposon-derived regulatory 
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mechanisms have been developed to keep the transposition activity at the desired 
level. In most instances, transposase is the only requirement for transposition. 
Therefore, the control of transposition is often limited to the regulation of the ex-
pression of this protein. Regulation of transposition is specific for each element 
and includes regulation at the levels of transcription, differential splicing, transla-
tion, and protein-protein interactions. 
In most cases, the expressed protein is already tempered as conserved sequence of 
the transposase does not translate into the most active protein. Mutagenizing the 
Sleeping Beauty in our laboratory led to creation of a transposase 100 times more 
active than the originally created transposase [Mátés, 2009], [Ivics, 1997]. 
Mutagenesis resulting in creation of hyperactive transposases was performed also 
for Himar1 [Lampe, 1999], Mos1 [Pledger, 2005] and Tn5 [Naumann, 2002]. 
Endogenous transposase promoters are generally weak and many are partially 
located in the terminal IRs. This would enable their autoregulation by the transpo-
sase binding. The transposase promoters can be also bound by repressor proteins. 
The Mu repressor is a transpositional inhibitor that can also act as a transcriptional 
repressor of the transposase gene [Krause, 1986]. Transposition of some transpos-
able elements is regulated by DNA adenine methylation. The methylation of the 
promoter region of the maize Ac/Ds elements reduces the transcription of active 
elements almost completely [Fedoroff, 1983], [Kunze, 1996]. In the case of other 
maize transposon, En/Spm, methylation of two regions close to the transcription 
start site inactivates the promoter. Additionally, the methylation reduces the exci-
sion frequency even when transactivated by an active En/Spm element [Schläppi, 
1993]. In series of bacterial elements, including IS10, Tn903 and Tn5, increase in 
transposase expression levels and transposition frequency was observed in methy-
lation deficient dam- strains [Roberts, 1985], [Yin, 1988]. 
In bacterial element, IS200, two sets of internal inverted repeats generate RNA 
secondary structures providing two independent mechanisms for repression of 
transposase synthesis [Beuzón, 1999]. One set forms a hairpin that terminates 
read-through transcripts before they reach the IS200 ORF. Any impinging tran-
script which escapes the terminator will encounter a step-loop element that oc-
cludes the ribosome-binding site for the transposase gene, thus functioning as 
translational inhibitor. This double expression repression significantly decreases 
the levels of the IS200 transposase. 
In nematodes, RNA interference (RNAi) has been found to be a major mechanism 
for transposon silencing (reviewed in [Vastenhouw, 2004]. RNAi is the post-
transcriptional silencing of a gene. Protein components of the RNAi machinery 
process double-stranded RNA (dsRNA) into small interfering RNAs (siRNAs) 
that mediate degradation of the sequence-complementary transcript. The dsRNA 
substrate for transposon silencing may arise from a transcription through the 
whole transposon including both inverted repeats. The two halves of the resulting 
transcript are complementary and can fold into an RNA hairpin. Moreover, the 
read-through transcription can occur both in a sense and antisense direction ena-
bling the formation of dsRNA over the full length of the transposon. There is a 
growing evidence that RNAi is one of the mechanisms regulating transposition 
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levels in plants [Slotkin, 2009], fungi (Nolan et al., 2005) and animals [Houwing, 
2007] including human [Yang, 2006]. 
Translational control of transposition by frameshifting has been demonstrated for 
IS1 [Sekine, 1989], [Luthi, 1990] and for members of the IS3 family [Polard, 
1991], [Chandler, 1993] but may also occur in several other transposable ele-
ments. The upstream frame appears to carry a DNA recognition domain whereas 
the downstream frame encodes the catalytic site. The product of the upstream 
frame alone acts as a modulator of activity, presumably by binding the IR se-
quences. Frameshifting assembles both domains into a single transposase protein 
responsible for the mobility of the element. The frameshifting frequency is thus 
critical in determining overall transposition activity and could be possibly influ-
enced by host physiology, thus coupling transposition activity to the state of the 
host cell. 
En/Spm encodes a series of proteins that arise by alternative splicing. Two pro-
teins, TnpA and TnpD, have been implicated in the transposition process. Other, 
such as TnpB and TnpC, are not essential but appear to play a role in regulating 
transposition [Masson, 1991]. Their structure suggests that they may act as nega-
tive regulators of the Spm transposase function. Interestingly, TnpA is a unique 
regulatory protein, as it is able to activate the inactive, methylated Spm promoter 
and to repress the active unmethylated promoter [Schläppi, 1994]. For the repres-
sion a DNA-binding and dimerization domains are necessary, whereas for the 
activation an additional C-terminal sequence of TnpA is required. 
Shorter transposase versions may arise from translation from different start 
codons or from proteolytic cleavage of the expressed protein. If such proteins 
retain DNA-binding ability but the catalytic domain is disrupted, they can 
compete for DNA-binding with full-length transposase but will not form proper 
complexes. For several transposases, the N-terminal part of the protein exhibits 
higher affinity for the transposon ends than the entire transposase molecule. In 
such case, releasing the N-terminal DNA-binding domain would result in 
significant competitive inhibition. (Additionally, this fact suggests that the C-
terminal end may in some way mask the strong DNA binding activity of the N-
terminal domain.). 
Another transposon-derived regulatory mechanism is overproduction inhibition 
(OPI). High levels of the transposase strongly decrease the overall transposition 
activity. The phenomenon has been observed for bacterial, plant and vertebrate 
transposons [Weinreich, 1994], [Kunze, 1993], [Geurts, 2003]. The mechanism is 
not completely understood, but based on studies on Mos1 mariner element it has 
been suggested that OPI results from posttranslational interactions between wild-
type transposase molecules [Lohe, 1996]. The transposase monomers, when pre-
sent in excess concentration, form inactive or weakly active oligomers. The OPI 
was also observed for Sleeping Beauty [Zayed, 2004]. 
As described above, there are many different mechanisms keeping the transposi-
tion at low level. However, to avoid genome rearrangements, not only the quantity 
of the “jumping” but also the quality of the process matters. The cut-and-paste 
transposition mechanism can be divided into four main steps: 1) binding of the 
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transposase to the transposon DNA; 2) formation of a paired-end-complex; 3) 
excision from the donor site; 4) target capture and reintegration at a target site 
(Abb. 3). Imprecision during complex formation or excision could lead to cleav-
age within the adjacent genomic DNA and taking up additional sequences or leav-
ing part of the transposon DNA behind. To ensure precise transposition process, 
regulatory “checkpoints” exist, at which certain conditions have to be met for the 
reaction to proceed. 
Once the transposase recognized its specific DNA ends, the complex can start to 
form. For some transposons the complex formation has been studied very deeply 
and there is evidence that it is a multistep complex reaction. Proteins of the DDE 
family require for the reaction the presence of Mg2+ ions for catalytic activity. 
Substitution for Ca2+ ions allows the complex formation but no catalytic reactions. 
It has been reported for mariner that in vitro transposition took place in presence 
of  Mn2+ but the efficiency of the reaction was changed (15-fold lower than with 
Mg2+, [Tosi, 2000]; 10-fold higher than with Mg2+, [Zhang, 2001]. Interestingly, 
only half of the insertions took place at TA dinucleotide, whereas the rest was 
random. Similar observations were made for Tn10 [Junop, 1997]. The Drosophila 
P element requires for the process not only the presence of the divalent metal ions 
but, uniquely, also GTP [Kaufman, 1992]. First, the transposase binds to one of 
the two P element ends, in the presence or absence of GTP. However, in the ab-
sence of GTP, such complex remains stable but can not proceed to synapsis [Tang, 
2005]. 
Biochemical studies of Tn5 transposase demonstrate that N-terminal DNA-
binding domain and C-terminal catalytical domain inhibit each other’s activities. 
No monomeric DNA-protein complexes have been detected when the full-length 
Tn5 transposase was used, whereas C-terminal deletion proteins could easily form 
complexes [Weinreich, 1994], [York, 1996]. These results are supported by struc-
tural analysis [Davies, 2000] and suggest that the full-length transposase must 
undergo a conformational change to relieve its activities. Importantly, the paired-
end-complex formation, where two transposon ends are brought in close prox-
imity, is a prerequisite for the catalytic activities, as Tn5 transposase acts in trans. 
It means that the transposase bound to one transposon end process the cleavage of 
the second transposon end [Naumann, 2000]. If proper complex formation fails, 
no excision would take place. This feature is shared by Mu [Savilahti, 1996] and 
most probably by other bacterial transposases. In contrary, mariner-like element 
Himar1 was reported to form active complexes on one transposon end in vitro 
[Lipkow, 2004]. mariner transposases exist in solution as monomers, but are 
bound to a single inverted repeat (IR) on each end of the transposon as a dimer 
[Augé-Gouillou, 2005]. On the other hand, Butler and colleagues argue that mari-
ners might bind as monomers and then quickly recruit another monomer to form a 
very stable dimer [Butler, 2006]. Nevertheless, once the dimer is bound, it is able 
to interact with similar IR-dimer complexes forming a paired-end-complex. How-
ever, a dimer of the transposase bound to one transposon end was able to cleave it 
when supplied with Mg2+ ions [Lipkow, 2004]. 
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For Sleeping Beauty, there are many unanswered questions about the paired-end-
complex (PEC) formation. It is known that a tetramer of the transposase is present 
in the PEC, however, how the complex forms has not been revealed. In this work I 
tried to dissolve the cascade of single steps and “checkpoints” necessary to form 
proper PEC that could undergo catalytic reactions. 
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2 MATERIALS AND METHODS 
 
 
2.1 Materials
 
2.1.1 Bacterial strains 
Plasmids were maintained in: 
 E.coli DH5  
Expression of the proteins was performed in: 
 E.coli BL21(DE3) CodonPlus RIL 
 E.coli BL21(DE3) Rosetta pLysS 
In vitro transposition assay was selected in: 
 E.coli DH10 
Bacterial strains were routinely grown at 37 C in LB medium 
Luria Bertani medium: 10 g bactotryptone 
 5 g bacto-yeast 
 10 g NaCl 
 dissolved in H2O until 1 liter 
Medium was sterilized by autoclaving and before use supplemented with the ap-
propriate antibiotic (15 g/ml of kanamycin or 100 g/ml of ampicilin). 
 
2.1.2 Plasmids
Plasmids available in the lab stocks of Zs. Izsvak’s and Z. Ivics’ groups: 
 pET-21a/N57 and pET-21a/58-123 expressing hexahistidine-tagged subdo-
mains of the SB DNA-binding domain, PAI and RED, respectively [Izsvak, 
2002]; 
 MBP-SB, plasmid expressing SB fused to maltose-binding protein [Zayed, 
2003]; 
 pET28/HMGB1 expressing hexahistidine-tagged version of HMGB1 was 
kindly provided by M. Bianchi, Milan, Italy (described in [Aidinis, 1999]; 
 pCMV-SB10 [Ivics, 1997] and pCMV-SBD3, a catalytic mutant (E278D) of 
SB were used for expression of the SB transposase in HeLa cells; 
 pCMV, plasmid expressing -galactosidase used as a negative control in in
vivo assays 
 transposon donor construct pT/neo [Ivics, 1997]; 
 pT/out, a version of pT/neo containing in the right IR only the sequence of 
outer DR (constructed by Zoltan Ivics) 
 pCMV-Hsmar1-Ra expressing an active version of Hsmar1 transposase 
[Miskey, 2007]; 
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 pHsmar1-neo and pHsma1-neoleft lacking the right IR [Miskey, 2007]; 
Plasmids cloned during the project: 
 pT/in, a version of pT/neo containing in the right IR only the sequence of in-
ner DR followed by the TA dinucleotide; 
 5ir and 5or, pT/neo constructs with mutations introduced into the RED recog-
nition motif of inner and outer DR of the right IR, respectively; 
 pTzeo/ss – a pACYC184 plasmid with rpsL (streptomycin-sensitive allele) 
and sacB (sucrose sensitive gene) inserted as a BglII-EagI cassette and with a 
transposon DNA carrying zeocin resistance cloned into EcoRI and NruI sites 
(disrupting the CmR gene) 
 STREP-JAZZ-SB was made by PCR amplification using three primers add-
ing the tags N-terminally to the SB. The PCR product was then cut with 
BamHI and cloned into the BamHI site of the pIRES1hyg (CLONTECH) vec-
tor yielding a eukaryotic expression vector and into NheI site of pASK-
IBA13plus (IBA BioTAGnology) yielding a bacterial expression vector; 
 
2.1.3 Chemicals
alfa-32dATP and alfa-32dCTP PerkinElmer 
Agarose MP Biomedicals 
Amylose resin NEB 
Anhydrotetracycline (AHT) IBA BioTAGnology 
Antibiotic-antimycotic Gibco/Invitrogen 
Antibiotics (ampicilin, kanamycin) Serva 
Ammonium persulfate (APS) Sigma 
beta-mercaptoethanol Sigma 
bis(sulfosuccinimidyl) suberate (BS3) Pierce 
Bovine Serum Albumin (BSA) Sigma 
bromophenol blue sodium salt Sigma 
COMPLETE Mini Tablets Roche Diagnostics 
Coomassie Brilliant blue R-250 Serva 
dimethylsulphoxide (DMSO) Sigma 
dNTPs (100mM each) GE Healthcare 
dithiothreitol (DTT) Sigma 
Dulbecco’s modified Eagle’s medium (DMEM) Gibco/Invitrogen 
EDTA Serva 
ethanol Roth 
ethidiumbromide Merck 
Fetal Calf Serum (FCS) PAA 
formaldehyd 37% Roth 
GeneRuler 1 kb Ladder Plus Fermentas 
geneticin (G418) Biochrom 
glycerol 86% Roth 
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glycine Roth 
HEPES Sigma 
imidazole Sigma 
isopropyl-beta-D-thiogalactopyranoside (IPTG) Sigma 
jetPEI RGD Polyplus Transfections 
maltose Fluka 
methanol Roth 
Ni-NTA agarose Qiagen 
N,N,N',N'-Tetramethylethylenediamine (TEMED) Sigma 
Nonfat dried milk powder AppliChem 
Nonidet P-40 (NP-40) Fluka 
PEI 25 kDa (linear polyethylenimine) Polysciences 
Phosphate buffered saline (PBS) PAA 
potassium acetate Sigma 
potassium chloride (KCl) Merck 
Precision Plus Protein Standards All Blue Biorad 
2-Propanol Roth 
ProtoGel 30%Acrylamide:0.8%Bis-Acrylamide National Diagnostics 
Roti-Phenol/Chloroform/Isoamylalcohol Roth 
sodium chloride (NaCl) Fluka 
sodium dodecyl sulfate (SDS) Serva 
Trizma Sigma 
Trypsin-EDTA, 5% Gibco/Invitrogen 
Tween-20 Merck 
oligonucleotides for cloning Biotez, Berlin 
 
2.1.4 Kits
QIAGEN Plasmid Mini and Midi Kits QIAGEN 
QIAquick Gel Extraction Kit QIAGEN 
QIAquick PCR Purification Kit QIAGEN 
MicroSpin G-25 Columns GE Healthcare 
Ni-NTA Spin Columns QIAGEN 
Strep-Tactin Spin Column Kit IBA Biotechnology 
ECL Plus Western Blotting Detection System GE Healthcare 
pGEM-T Vector System Promega 
 
2.1.5 Enzymes and antibodies 
Restriction enzymes NEB, Amersham, Fermentas 
Taq polymerase Inviteq 
Pfu polymerase Stratagene 
T4 DNA ligase Fermentas 
Shrimp alkaline phosphatase Fermentas 
Klenow fragment Fermentas 
DNase I Invitrogen 
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Proteinase K Invitrogen 
 
Primary antibodies: 
 Monoclonal Anti-Sleeping Beauty Transposase Antibody (R&D Systems) 
1:500 
 Polyclonal Anti-Sleeping Beauty Transposase Antibody (R&D Systems) 
1:1000 
Secondary antibodies: 
 Goat Anti-Mouse IgG, Peroxidase Conjugated (Pierce Biotechnology) 1:5000 
 Mouse Anti-Goat IgG, Peroxidase Conjugated (Pierce Biotechnology) 1:2000 
 
2.1.6 Buffers
Buffers for electrophoresis of DNA 
TBE buffer 90 mM Tris-Borate, pH 8.3 
 1 mM EDTA 
Loading buffer (5x concentrated) 50% glycerol 
 bromophenol blue 
Buffers for electrophoresis of proteins 
Running buffer 25 mM Tris, pH 8.3 
 250 mM glycine 
 0.1% SDS 
Laemli buffer (4x concentrated) 0.25 M Tris, pH 6.8 
 5% SDS 
 10% -mercaptoethanol 
 40% glycerol 
 bromophenol blue 
Coomassie Blue staining solution 0.2% Coomassie Brilliant Blue R-250 
 50% methanol 
 10% acetic acid 
Western blotting  
Transfer buffer 25 mM Tris, pH 8.3 
 192 mM glycine 
 20% methanol 
TTBS buffer 50 mM Tris, pH 7.5 
 150 mM NaCl 
 0.1% Tween 20 
Electromobility Shift Assay  
Running buffer 25 mM Tris, pH 8.3 
 190 mM glycine 
 1 mM EDTA 
Cell culture  
Fixing solution 10 % formaldehyde in PBS 
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Staining solution methylene blue in PBS 
 
2.1.7 Apparatus
ABI Prism 3100 DNA Sequencer Applied Biosystems 
Agigateur Top-Mix 11118 Bioblock Scientific 
BioDocAnalyze Biometra 
Centrifuge 4K15C Sigma 
Centrifuges 5415D, 5417R, 5810R Eppendorf 
Fluorescent Image Analyzer FLA-3000 Fujifilm Life Science 
Gelelectrophoresis, Mini-Sub Cell GT Gel 
System 
Biorad 
Gene Pulser II Biorad 
Image eraser Raytest Isotopenmeßgeräte 
Incubators for cell lines Binder 
Incubators for bacteria Heraeus 
Microscope Axiovert 25 Zeiss 
Nanodrop Peqlab 
Optimax X-Ray Film Processor Protec Medizintechnik GmbH 
PCR Cycler Peltier Thermal Cycler-200/225 MJ Research 
pH-meter VWR International 
Pipetboy Brand 
Pipettes, Pipetman Gilson 
Power supply electrophoresis Biorad 
SDS-PAGE, Mini-Protean Biorad 
Shaker, MTS4 Ika 
Spectrophotometer, ND-1000 Peqlab 
Thermomixer compact Eppendorf 
Vertical Gel Electrophoresis Apparatus, 
V15.17 
Life Technologies 
Waterbath Julabo 
 
 
2.2 Methods
 
2.2.1 Protein purifications 
 E.coli BL21(DE3) CodonPlus RIL strain containing plasmid expressing MBP-
SB fusion protein was grown to OD600 ~0.5 and after induction with 0.3 mM 
IPTG the growth continued for 2h at 37ºC. Purification was done as described 
in [Zayed, 2003] with small modifications. Bacterial pellet was resuspended in 
CB buffer (20 mM Tris pH 7.4, 200 mM NaCl, 1 mM EDTA and 1 mM DDT) 
containing protease inhibitors, DNase I and PEI and sonicated 6 times 15 sec-
onds with 1 minute breaks. The pellet was resuspended in CB with 750 mM 
NaCl and centrifuged. The supernatant was loaded onto amylase resin equili-
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brated in CB buffer. After washing steps, the fusion protein was eluted with 
CB buffer containing 10 mM maltose. 
 Vector expressing STREP-SB was transformed into E.coli BL21(DE3) 
CodonPlus RIL and the bacterial culture was grown to OD600 ~0.6. After in-
duction with 20 g AHT the growth continued for 3h at 30ºC. Harvested bac-
teria was then resuspended in lysis buffer (50 mM NaH2PO4 pH 7.5, 500 mM 
NaCl) containing 1 COMPLETE Mini Tablet and sonicated in cycles 6 times 
10 seconds separated with one minute break. After 20’ centrifugation at 14 
krpm the supernatant and the pellet were resuspended in Laemli buffer and 
analyzed on the SDS-PAGE gel. 
 E.coli BL21(DE3) CodonPlus RIL strain was induced at OD600 ~0.6 with 20 
g AHT to express STREP-JAZZ-SB. After 4h growth at 30ºC the bacteria 
was centrifuged and the pellet resuspended in L-buffer (25 mM Tris 7.5, 250 
mM NaCl and 1 mM EDTA) containing COMPLETE Mini Tablet and DNase 
I and sonicated (6 times 15 seconds with 1 minute intervals). The supernatant 
was loaded on equilibrated Strep-Tactin Column which was then washed with 
buffer W and STREP-JAZZ-SB was eluted with buffer E (both included in the 
kit). 
 Expression and purification of His-tagged PAI and RED subdomains were 
conducted as described in [Izsvak, 2002]. Briefly, E.coli BL21(DE3) were in-
duced at OD600 ~0.5 by the addition of IPTG to a final concentration of 0.4 
mM and grown for 3h at 30ºC. Pellet was sonicated in H-buffer (25 mM 
HEPES pH 7.6, 1 M NaCl, 15% glycerol, 0.25% Tween20, 2 mM -
mercaptoethanol and a COMPLETE Mini Tablet) and the supernatant ob-
tained after centrifugation was loaded on a Ni-NTA slurry equilibrated in H-
buffer. After 2h incubation on a rotor at 4ºC the beads were washed with H-
buffer containing 30 mM imidazole and bound proteins were eluted with H-
buffer with 300 mM imidazole. 
 The His-tagged HMGB1 was expressed in E.coli BL21(DE3) upon addition of 
0.8 mM IPTG at OD600 ~0.6 and growth at 300C for 4h. The bacterial pellet 
was resuspended in lysis buffer (50 mM NaH2PO4 pH 7.8, 300 mM NaCl and 
10 mM imidazole) containing 1 COMPLETE Mini Tablet and sonicated. Puri-
fication was done on Ni-NTA Spin Columns according to the manufacturer’s 
protocol. 
 
2.2.2 SDS-PAGE and Western Blot Analysis 
Purifications steps of the tagged full-length transposases were checked on the 
12.5% polyacrylamide gels. Purifications steps of the tagged subdomains, His-
PAI and His-RED, as well as His-HMGB1 were separated on 15% polyacryla-
mide gels. The gels were run at 150 V, stained in Coomassie Blue solution for 30 
minutes and distained incubating several times in warmed-up water. 
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To perform Western blot analysis, proteins from the gel were transferred onto 
nitrocellulose membrane (Amersham Biosciences) at 80 V for 1 hour 15 minutes 
in cooled transfer buffer. Membranes were blocked with 5% milk powder in 
TTBS for one hour at room temperature or overnight at 4C. Then, the mem-
branes were incubated with primary antibodies for two hours at room temperature 
or overnight at 4C. After washing three times for 5 minutes with TTBS, the 
membranes were incubated with secondary antibodies for two hours at RT. The 
membranes were washed 5 times for 5 minutes with TTBS and the bound antibod-
ies were visualized by chemiluminescence (ECL Plus Western Blotting Detection 
System). 
 
2.2.3 Electromobility Shift Assay (EMSA) 
Double-stranded oligonucleotides corresponding to the inner or outer DR were 
end-labeled using [alfa-32P]dCTP and Klenow fragment. The DNA probe contain-
ing the left IR was cut out from the pT/neo using EcoRI restriction enzyme and 
end-labeled with [alfa-32P]dATP using Klenow fragment. After the Klenow reac-
tion labeled DNA was purified from nucleotides and protein using MicroSpin G-
25 Columns as described by the manufacturer. 
Binding reactions were performed in 20 mM HEPES (pH 7.5), 0.1 mM EDTA, 1 
mM DTT in a total volume of 10 l. 20000-50000 cpm labeled DNA probe and 
various concentrations of the proteins (as noted in the figures) were added and 
incubated 10 min on ice. After addition of 3 l of loading dye (containing 50% 
glycerol and bromophenol blue) the samples were loaded onto a 4% or 6% poly-
acrylamide gel. The electrophoresis was carried out in Tris-glycine buffer pH 8.3 
at 25mA for 2-3 hours. Then, the gels were dried for 45 minutes using the gel 
dryer from BIO-RAD. After overnight exposure the gels were scanned with Fuji-
film FLA-3000 and analyzed with AIDA program. 
 
2.2.4 Chemical crosslinking 
Reactions were performed using the bis(sulfosuccinimidyl) suberrate (BS3) ac-
cording to manufacturer’s recommendations. Proteins (3M) were incubated on 
ice in 20 mM HEPES pH 7.5, 5 mM MgCl2, 100 mM NaCl and 2.5 mM BS3 in a 
final volume of 15 l. After 2 hours the reactions were stopped by adding Tris pH 
7.5 to a final concentration of 50 mM and incubating 10 min at room temperature. 
Then the Laemli buffer was added and samples were loaded on 15% SDS-PAGE 
and analyzed by Western blotting using polyclonal anti-SB antibody and secon-
dary anti-goat IgG. 
 
2.2.5 Cell culture and in vivo assays 
HeLa cells were grown in DMEM supplemented with 10% Fecal Calf Serum 
Gold and 1% antimycotic antibiotic. One day prior transfection cells were seeded 
onto six-well plates. Cells were transfected with Qiagen purified DNA using jet-
PEI RGD transfection reagent or 25kDa linear PEI in 150 mM NaCl. Two days 
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posttransfection half of the cells was harvested for excision assay and half was 
plated out on 10 cm dishes for selection using 1 mg/ml G418. After 3 weeks of 
selection, colonies were fixed with 10% formaldehyde and stained for 1 hour with 
methylene blue. After drying the plates were photographed and the colonies 
counted [Ivics, 1997]. 
To perform the excision assay plasmid DNA was isolated from harvested cells 
using the QIAprep Spin Miniprep protocol with small modifications. That is, in-
stead of the P2 buffer, 1.2% SDS and 0.1 μg/μl Proteinase K was added. DNA 
was eluted in 50l Elution Buffer and 2 l was used as template for PCR. The 
PCR was performed with Taq polymerase and 10 pmol of primers aligning to the 
pUC19 backbone sequence in order to obtain the excision site. 
 
PCR program: 94ºC - 94ºC – 65ºC – 72ºC – 72ºC – 4ºC 
 5’   -  30”  -   30”  -   30”  -   5’   -    
 30 cycles 
 
The PCR product was diluted 1:100 and 1 l was subjected to another round of 
PCR with nested primers. The products were visualized on the 1.2% agarose gel. 
To normalize the PCR conditions for excision assay, a PCR for ampiciline gene 
was performed using 15 cycles of the PCR program. 
 
2.2.6 Analysis of excision and insertion sites 
In order to analyze the excision sites obtained PCR products were cut out from the 
gel and the DNA was extracted with QIAquick Gel Extraction Kit. Then, the 
DNA was cloned into pGEM-T vector system, the positive colonies were picked 
and the sites were sequenced using the T7 primer. 
To analyze the integration profile of the T2 construct a transposition assay in 
HeLa cells was performed. After 2 weeks of G418 selection the resistant clones 
were picked and transferred to 6-well plates. They were kept in culture for several 
days to grow in size and when the wells were full, cells were washed with PBS 
and 1 ml of lysis buffer (10 mM Tris pH 8.5, 5 mM EDTA, 0.5% SDS, 200 mM 
NaCl and 100 g/ml Proteinase K) was added onto the cells. After overnight in-
cubation at 37ºC the lysed cells were transferred to eppendorf tubes and the DNA 
precipitated. To the pellet 200 l TE with RNase was added and incubated over-
night at 55ºC with moderate shaking to dissolve the genomic DNA. 1 g of the 
DNA was digested with BglII and BclI restriction enzymes, precipitated and 
ligated overnight at 16ºC in a large volume to allow the DNA fragments to circu-
larize. After precipitation the DNA samples were resuspended in 30 l TE buffer 
and 2 l was used as template for PCR reactions. Nested PCRs were conducted 
with primers aligning to the neomycin resistance gene and inverted repeat se-
quences. Obtained products were extracted from the gel and sequenced. 
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2.2.7 In vitro transposition assay 
200 ng donor (plasmid containing transposon sequence) DNA was incubated to-
gether with 50 ng of purified transposase fusion protein in buffer containing 25 
mM HEPES, 100 mM KCl, 5 mM MgCl2 and 1 mM DTT. For some reactions the 
buffer was enriched with 10 % glycerol, 10 % DMSO and/or 0.02 % NP40. Addi-
tionally, different ratios of DNA and protein were used. Some reactions were sup-
plied with 50 ng of purified His-HMGB1 and/or 10 ng of BSA. After 30 minutes 
incubation at 4ºC 2 g target DNA was added and incubated 3 hours or overnight 
at 30ºC. The reactions were stopped by adding 5 % SDS, 2 mg/ml proteinase K 
and 50 mM EDTA in 25 mM HEPES and incubating at 55ºC for 1 hour. After 
phenol-chlorophorm extraction the DNA was precipitated (0.6 volume of isopro-
panol, 0.1 volume of 2.5 M KoAc and 1 l glycogen), washed twice with 70 % 
ethanol and the pellets were resuspended in 10 l H20 and electroporated into 
DH10B cells. To recover the transposition events the cells were selected on LB 
agar containing ampicilin, zeocin, streptomycin and sucrose. 
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3 AIM OF THE PROJECT 
 
 
Transposons are widely spread in nature. The transposition has to be controlled in 
order to keep the process at low level. Uncontrolled transposition could be delete-
rious to the host and thus to the transposon itself. That is why both, transposon 
and the host, developed mechanisms regulating transposition reaction. 
Until the resurrection of the Sleeping Beauty [Ivics, 1997] no active vertebrate 
transposon was available. The SB system is now being developed as a tool for 
insertional mutagenesis as well as a vector for gene therapy. Studies of SB trans-
position in vitro and regulatory mechanisms of the process would provide infor-
mation essential for the optimization of transposition recoveries in vivo. There-
fore, the aim of the project was to understand the single steps of the transposition 
reaction and to establish an in vitro assay for Sleeping Beauty transposition. In-
sights into the process and knowledge about conditions required for each step of 
the reaction would help in future work and use of the transposon system. The in
vitro assay would serve a quick and easy assay for testing the system and probe 
mechanisms affecting the regulation of transposition activity. 
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4 RESULTS PART I - Regulated complex assembly 
 
 
4.1 IR/DR structure of Sleeping Beauty
 
Sleeping Beauty belongs to IR/DR subfamily of Tc1/mariner transposons. The 
IR/DR structure refers to two Inverted Repeats (IR) each having two Direct Re-
peats (DR) flanking an open reading frame coding for the transposase. The in-
verted repeat upstream of the gene is commonly called left IR and the inverted 
repeat downstream of the gene, right IR. Each IR is approximately 230bp long and 
has two 30bp long DRs serving as binding sites for the transposase. All four bind-
ing sites are necessary for the transposition process, as deletion of one of them has 
a strong negative effect on the transposition efficiency. Experiments performed in 
our laboratory (by Christopher D. Kaufman, Abb. 4) revealed that removing one 
binding site from the left IR abolishes transposition, whereas removing one or 
both binding sites from the right IR strongly decreases transposition. Additionally, 
the distance between the binding sites matters as removing this sequence abol-
ished transposition [Izsvak, 2002]. Moreover, the position of the outer and inner 
binding sites can not be freely exchanged with each other [Cui, 2002]. Not only 
are the presence of all binding sites, but also the combination of the inter-DR 
spacing and geometry of the DRs important for the transposition process. In SB 
system all binding sites are occupied by the transposase proteins and the active 
nucleoprotein complex is composed of transposase tetramer bringing two transpo-
son ends together [Izsvak, 2002]. Similar complex is formed for Tc3, another 
Tc1/mariner element with four binding sites. Interestingly however, deletion of 
inner binding sites of the Tc3 transposon DNA does not abolish its transposition 
[Colloms, 1994]. 
mariner-like elements form the second subfamily of the Tc1/mariner transposons. 
In contrast to SB, mariners have short IR with only one binding site each. Impor-
tantly, elements deprived of the right IR showed moderate transpositional activity. 
Formation of active complexes on single transposon end, without the second end 
in the complex, was reported for the mariner-like element, Himar1 [Lipkow, 
2004]. It means that a transposase dimer formed on one binding site is able to 
cleave the transposon end. 
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Abb. 4: SB requires all binding sites for proper transposition. On the top, the DNA 
structure of the SB transposon with yellow and green triangles referring to outer and inner 
binding sites (DR), respectively. Deletion of one (construct 1) or both (construct 2) direct 
repeats from the left inverted repeat completely abolishes transposition and deletion of 
one (construct 3) or both (construct 4) direct repeats from the right inverted repeat 
strongly decreases the transposition efficiency in transposition assays in vivo. 
 
Since transposon integration events with SB construct having only one transposon 
end were detected (Abb. 4, construct 4), suggesting that SB transposase is as well 
able to form active complexes on one inverted repeat, I wanted to test and com-
pare the frequencies of single-end cleavage of Sleeping Beauty and a mariner-like 
element. In order to do that, I subjected full-length (containing both inverted re-
peats) and left-arm (missing the right inverted repeat) transposons of SB and a 
mariner-like element, Hsmar1 [Robertson, 1997], together with their cognate 
transposase-expressing helper plasmids to in vivo transposition assay [Ivics, 
1997]. All transposons contain a neomycine resistance gene. Cells with transposi-
tion events can be then selected using G418 antibiotic. As negative controls, a 
plasmid expressing -galactosidase (pCMV) was used instead of plasmids ex-
pressing active SB and Hsmar1 transposases. Fischer and colleagues [Fischer, 
2001] compared transposition efficiency of SB and several other Tc1/mariner 
elements in transposition assays in HeLa cells. Similarly to their results, I ob-
served higher transposition efficiency for SB than for Hsmar1 (Abb. 5A). 
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Abb. 5: SB is capable of single-end-cleavage. A. transposon constructs carrying a neo 
resistance gene were cotransfected with a plasmid expressing either transposase or beta-
galactosidase. G418-resistant colonies were selected and counted. B. The transposition 
activity (indicated on the z axis) is the ratio of the number of resistant colonies obtained 
in the presence of the transposase over the resistant colony number obtained with -
galactosidase. The activity of the full-length transposons was set to 100%. The activity 
indicates an average of three independent transfections.
 
For all transposon constructs, full-length as well as left-arm, raise in colony num-
bers in comparison to negative controls was observed (Abb. 5A), indicating that 
both transposons are capable of single-end cleavage. However, the frequency of 
such events is significantly lower for Sleeping Beauty (Abb. 5B). As mentioned 
above, the main difference between SB and Hsmar1 systems is the inverted repeat 
structure. Additionally, the N-terminal DNA-binding domain of the SB transpo-
sase has a more composite structure. The domain consists of two helix-turn-helix 
motifs, called PAI and RED [Izsvak, 2002] (Abb. 2A), while the transposase of 
the Hsmar1 has only one HTH motif [Robertson, 1997]. Existence of two DNA-
binding subdomains within SB transposase may indicate more complex protein-
DNA interactions. I wondered what the function of the bipartite DNA binding 
domain is and performed experiments to learn more about the activities of the 
subdomains. 
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4.2 Functions of the bipartite DNA-binding domain of SB transposase 
 
In order to find sequences bound strongly by the DNA-binding domain of the SB 
transposase, a PCR-based CASTing experiment was performed in our laboratory. 
The CASTing method was developed to select optimal binding sites for DNA-
binding proteins [Wright, 1991]. Using footprinting data of SB transposase bind-
ing [Ivics, 1997], a 24 bp random oligonucleotide library was created and exposed 
to the DNA-binding domain of the transposase. Oligonucleotides selected in the 
CASTing experiment were sequenced and compared to the wild type binding 
sites. The binding sites for the SB transposase are very similar, but not identical, 
showing 3 nucleotides differences in sequence and 2 nucleotides differences in 
length (Abb. 2B). From footprinting data it was known that PAI recognizes the 3’-
part of the binding site, whereas RED recognizes the 5’-part [Izsvak, 2002]. Sur-
prisingly, all of the selected sites showed similarity only to the PAI recognition 
motif, whereas the RED recognition site was fairly random. Interestingly, when 
the PAI recognition sequences within the inner binding sites were changed to one 
of the high affinity binding sites (the RED recognition sites were left wild-type), 
no significant raise in transposition rate was observed in transposition assay in 
cells. Replacement of the PAI recognition motif within the outer binding sites led 
to the drop of the transposition frequency (experiment by Christopher D. Kauf-
man). These unexpected results show that stronger substrate binding does not lead 
to better transposition suggesting that enhancing one step of the reaction may dis-
turb the following steps. 
Additionally, the randomness of the RED recognition site would suggest that the 
RED is not involved in the primary substrate binding and only the PAI is respon-
sible for the primary interaction to its DNA substrate. This result raises also the 
question, what is the function of the RED subdomain? 
It has been shown that the N-terminal PAI subdomain is not only able to recog-
nize and bind the SB DNA, but has also a protein-protein interaction interface 
[Izsvak, 2002]. To study the activities of the RED subdomain, I purified a His-
tagged fusion of the RED and performed electrophoretic mobility shift assay 
(EMSA) and cross-linking experiment with it. EMSA is an electrophoresis tech-
nique used to detect and study protein-DNA interactions. When the protein is able 
to bind given DNA, the formed complex migrates slower in the gel resulting in 
appearance of an additional shifted band. 
SB binding was previously tested using either the entire IR or oligonucleotides 
corresponding to inner and outer DRs [Zayed, 2003]. Subjecting the RED subdo-
main to EMSA together with inner binding site resulted in appearance of one 
shifted band (Abb. 6A, well 2). Although PAI and RED subdomains are of very 
similar molecular mass, the shift of the RED-DNA complex is visibly stronger 
(compare lane 2 and 3 in Abb. 6A). This slower migration could suggest that a 
dimer of the RED binds the oligos or that the RED dimerizes quickly after DNA 
binding. Titrating the RED, I did not observe bands that could correspond to RED 
monomer in complex with DNA (data not shown).  Additionally, to confirm the 
 35
ability of the RED to oligomerize, a cross-linking with chemical crosslinker BS3 
was conducted. Clearly, RED dimers and tetramers were formed upon incubation 
with BS3 (Abb. 6C). 
 
 
Abb. 6: RED subdomain has DNA-binding and protein-protein interaction activity. 
A. demonstration of the DNA binding ability of the RED subdomain in EMSA (lane 2). 
The oligonucleotides corresponding to DRs were incubated with or without the PAI and 
RED subdomains and separated on 6% polyacrylamide gel. The molecular composition 
of each complex is shown on the right and the left of the gels; B. binding assay testing the 
ability of the RED subdomain to bind the inner DR containing two additional adenosine 
nucleotides (inner DR+AA) (lane 4). C. multimerization of the RED subdomain in the 
presence of BS3 crosslinker. Formed oligomers were detected in Western blot with poly-
clonal antibodies against SB. M, D and T stand for monomer, dimer and tetramer, respec-
tively. 
 
An interesting feature of the RED subdomain was revealed by the EMSA per-
formed with the outer binding site. Even though RED was able to recognize and 
bind the inner DR, no binding to the outer DR was ever detected (Abb. 6A, lane 
5). The binding sites differ from each other in two base pair in length and three 
nucleotides in sequence (Abb. 2B). I performed EMSA with inner DR containing 
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two additional adenosines present in the outer DR. The oligonucleotide (called 
inner DR+AA, Abb. 6B) is of the length of the outer DR, however, retaining the 
rest of the inner DR sequence. No binding to such modified DNA was observed 
(Abb. 6B, compare lanes 2 and 4). Binding affinity of the RED subdomain is very 
specific, restricted to the inner binding site of the SB transposon, as introduction 
of two nucleotides abolishes the binding. Important for distinction between the 
inner and outer binding site by the RED subdomain is the length of the two DRs. 
The PAI subdomain was able to bind both DRs (Abb. 6A, lane 3 and 6); however, 
the inner DR was bound stronger. The stronger affinity of both subdomains to-
wards the inner binding site can suggest that the complex formation would start at 
the inner DR, distantly from the cleavage site. 
As RED did not recognize the outer binding site, I wanted to check whether the 
sequence is of importance for the transposition reaction at all. In order to see this, 
I exchanged the RED recognition motif within the outer DR of right inverted re-
peat for one of the random oligonucleotides selected in the CASTing experiment 
(leaving the PAI motif wild-type). Additionally, the same sequence was intro-
duced instead of the inner DR. Both constructs, 5ir and 5or, carrying the random 
site in the inner and outer DR, respectively, were subjected for a transposition 
assay in vivo, together with wild-type transposon and transposase as a positive 
control and mutant inactive transposase as a negative control. Although, drop in 
transposition efficiency was observed for both mutated transposons, it was more 
significant when the outer binding site was mutated (Abb. 7). Even though the 
RED subdomain did not show binding to the outer DR in EMSA experiments, 
data from transposition assays suggest that the RED-outer DR interaction must be 
important at some stage of the transposition reaction, as substitution for a random 
sequence strongly decreased the efficiency of the process. 
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Abb. 7: RED recognition motif of the binding sites plays important role in the trans-
position. Substitution of the RED recognition motif decreased transposition efficiency in 
HeLa cells. Standard errors of the mean are from three independent transfections. D3 
stands for inactive transposase mutant serving as a negative control. 
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4.3 paired-end complex (PEC) formation 
 
The transposon-transposase complex formation is believed to be a multistep reac-
tion with several DNA-protein and protein-protein interactions that take place in a 
regulated sequential manner. Previous EMSA experiments suggest that the pri-
mary binding starts at the inner DR, distantly from the cleavage site, and most 
probably upon binding the protein-protein interaction activity of the RED subdo-
main is released (Abb. 6). When excess of purified RED subdomain was supplied 
an additional band appeared in the binding experiment (Abb. 8A, lane 3 and 4) 
believed to be a dimer of the RED bound to two DNA molecules. To form PEC 
transposase has to interact with both ends of the transposon DNA. Appearance in 
the EMSA of bands corresponding to higher complexes suggested that RED sub-
domain might be responsible for catching the other arm of the transposon. An 
EMSA was performed to check which DR, inner or outer, is incorporated as next 
one into the paired-end-complex. First, the RED subdomain was incubated with 
the inner binding site and then increasing amounts of radioactively labeled inner 
or outer binding sites were added (Abb. 8B). Upon addition of the inner DR in-
crease in higher complex formation was observed (Abb. 8B, lanes 2 to 4), whereas 
upon addition of the outer DR the complex was not formed (Abb. 8B, lanes 5 and 
6). This result implies that the transposase after forming a dimer on one inner 
binding site catches the second inner binding site. 
Incubation of increasing amounts of purified PAI subdomain with oligonucleo-
tides corresponding to the binding sites never resulted in formation of higher order 
complexes. Only one band could be observed (data not shown). These results sug-
gest that the PAI subdomain does not exhibit abilities to catch the second naked 
DNA. 
 
 
Abb. 8: RED catches the second transposon end. A. EMSA with increasing amounts of 
the purified RED subdomain. B. after the complexes are formed increasing amounts of 
labeled inner or outer DR are added to the reaction. Drawings on the left side of the gels 
show the molecular composition of each complex. ODR in lane 7 stands for outer DR 
alone. 
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It has been published that HMGB1 enhances binding of the SB transposase to the 
transposon IRs [Zayed, 2003]. HMGB1 is a nuclear protein binding the DNA in a 
sequence-independent manner and bending the DNA [Thomas, 2001]. Bending 
the DNA strand may bring two distant fragments in linear DNA in proximity. For 
transposons it would mean that HMGB1 brings closer the binding sites at the ends 
of the transposon DNA. For bacterial transposons presence of bending proteins, 
such as IHF and HU, in the complex formation has been reported [Krause, 1986], 
[Signon, 1995]. To test, whether HMGB1 influences DNA binding of the RED 
subdomain and the complex formation, the binding reactions were performed in 
presence and absence of HMGB1 and separated on the gel in electromobility shift 
assay (Abb. 9). Interestingly, when HMGB1 was present in the reaction the band 
corresponding to the paired-end complex was enhanced (compare lanes 2-4 and 5-
7 in Abb. 9). In the EMSA oligonucleotides corresponding to the binding site 
were used so the formed complex consists of a dimer of RED binding two single 
DNA molecules and not one bent DNA. Nevertheless, HMGB1 clearly enhanced 
formation of the higher order DNA-protein complex. The HMGB1 protein itself is 
not stably included in the complex or its interaction is not as strong as no super-
shift was observed and no shift when only HMGB1 was present (Abb. 9A, last 
lane). The mechanism of HMGB1 enhancement on DNA binding and formation 
of higher order complexes is not known. 
 
 
Abb. 9: HMGB1 enhances the RED binding to the DNA and catching of the second 
transposon end. A. electromobility shift assay of the RED subdomain in presence (lanes 
5-7) and absence of HMGB1 (lanes 2-4). The bands correspond to complexes shown on 
the left side of the gel. B. chemical cross-linking of the RED with HMGB1 (lane 3). In 
lane 2 cross-linking of the RED alone used as a control. 
 
HMGB1 was not only shown to enhance the SB binding to the transposon DNA 
but also to interact with the transposase [Zayed, 2003]. As I observed the influ-
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ence of HMGB1 on RED binding activity, I checked the protein-protein interac-
tion in the cross-linking experiment (Abb. 9B). When both proteins were incu-
bated together in presence of the BS3 two bands were detected (Abb. 9B lane 3, 
red triangles) that were not present without HMGB1 (Abb. 9B, lane 2). The size 
of approximately 37 and 45 kDa suggests complex of HMGB1 with a monomer 
and a dimer of the RED subdomain, respectively (29 kDa HMGB1 + 8 kDa RED). 
 
 
4.4 Cleavage
 
The paired-end complex formation of SB transposon system starts at the inner 
binding site, distantly from cleavage site. My EMSA experiments results suggest 
that the next binding site incorporated into the complex is the inner DR of the 
second IR. A dimer of the transposase brings two ends of the transposon together. 
The dimer can be an active transposase form for related mariner-like elements. 
Even though Himar1 PEC consists of transposase tetramer, a dimer bound to one 
transposon end was able to accomplish the catalytic activities [Lipkow, 2004]. We 
wondered whether the SB dimer bound to two inner DRs is able to process cleav-
age at the inner binding sites or in proximity to it. In order to test it, we planned to 
perform transposition and excision assays with truncated transposons with IRs 
ending with inner DRs. However, as deletion of outer binding site from the left 
inverted repeat results in complete abolition of the transposition reaction (Abb. 4, 
construct 1), the left IR had to be left unmodified. In the right IR only the se-
quence corresponding to the inner DR was present (Abb. 10A). At the DR-
backbone border I introduced the TA dinucleotide to mimic the cleavage site. Ad-
ditionally, the transposon carrying in the right IR only the outer binding site was 
included in the experiment (construct 3 shown in Abb. 4). Both constructs, called 
T/in and T/out, were transfected into HeLa cells together with a positive and nega-
tive control. The excision efficiency was tested in a PCR based assay recovering 
the excision site. Interestingly, excision product was detected for T/out, the trans-
poson with outer DR, but not for T/in, the transposon with inner DR, (Abb. 10C, 
lanes 4 and 5). The excision PCR is not a quantitative method, nevertheless, as the 
assay was normalized amplifying the ampiciline gene present in the backbone 
(Abb. 10B) und thus determining the input DNA, the efficiency could be roughly 
estimated (Abb. 10D, blue bars). Even though the constructs differ only in one 
binding site, what actually comes down to 3 bp difference in sequence and 2 bp 
difference in length, they exhibit significantly different activity in excision sug-
gesting existence of a mechanism preventing the cleavage at the inner DR. 
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Abb. 10: cleavage is inhibited at the inner binding site. A. schematic representation of 
the T/out and T/in transposons, carrying in the right IR only outer or inner DR, respec-
tively. B. the products of the PCR amplifying the ampicillin gene present in all vectors 
serving as the input control. C. the excision products detected in the PCR based excision 
assay. NT stands for non-transfected; neg stands for transfection with catalytically inac-
tive transposase. D. excision and transposition efficiency of modified transposons. The 
bars represent the average of three independent transfections. 
 
In transposition assay, both constructs showed significant decrease of the effi-
ciency, around 80% for the T/out confirming previous results (Abb. 4) and up to 
92% for the T/in (Abb. 10D, violet bars). Thus, the excision of the T/in took 
place, as low number of transposition events was formed in the colony based as-
say. However, the low level of excision was not detectable in the PCR based exci-
sion assay (Abb. 10C). The excision product of the T/out was sequenced to check 
the precision of the cleavage. Although canonical footprint was detected, most of 
the excision sites showed aberrancies. Additionally, individual G-418-resistant 
colonies were expanded to clones and the transposon integration sites were ana-
lyzed. Only proper insertion sites were found what may suggest that exclusively 
the transposons precisely excised from the donor site would undergo insertion into 
the new locus. 
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5 RESULTS PART II - Establishing an in vitro
transposition assay 
 
 
In vitro transposition assays have been established for some transposable elements 
such as yeast Ty1, bacterial Tn5 and ISY100, and insect Mos1 [Devine, 1994], 
[Goryshin, 1998], [Tosi, 2000], [Feng, 2007]. The lack of higher number of in
vitro assays can be due to the tight regulation of the process with strong require-
ments for proper conditions at each step and to dependence on the host factors. 
mariners seem not to require strict conditions as, as long as the transposase, donor 
(transposon) and target DNA, and divalent magnesium ions are supplied, they will 
jump [Tosi, 2000]. Studies of Tosi and Beverley provided information crucial for 
the design and application of new transposable elements for use in functional ge-
netic analysis. The data obtained facilitates the development of the in vivo system. 
Establishing an in vitro transposition assay for the Sleeping Beauty would yield 
information about the requirements for optimal run of the process and additionally 
afford an assay to explore the regulatory mechanisms affecting the SB transposi-
tion. Collected data would help in development of the system for gene therapy and 
mutagenesis applications. 
The activity of the SB system in a broad range of organisms, from fish, through 
amphibians and rodents to primates including human, suggests independence on 
the host factors [Izsvák, 2000]. However, the influence of host factors on SB 
transposition cannot be excluded. It is also possible that the host factors acting on 
the SB transposition are conserved through the vertebrate species. 
Based on the in vitro system of the closely related mariner transposon, in the SB 
in vitro assay the purified substrates are incubated together and then the transposi-
tion products are recovered and electroporated into E.coli (Abb. 11). The transpo-
son carries an antibiotic resistance gene between its inverted repeats resulting in a 
double-resistant target plasmid upon transposition. However, also bacteria that 
took up two separate plasmids may grow on double selection. To minimalize the 
background arising from electroporation of both plasmids, a donor plasmid with 
oriR6K (present also in the construct for Mos1 in vitro assay, [Tosi, 2000]) was 
used. oriR6K is origin of replication requiring the Pir protein for propagation. 
Virtually all common E.coli strains are pir- and thus, the donor plasmid contain-
ing the oriR6K should not be propagated in E.coli and only bacteria carrying 
transposition events can grow on double selection. However, the system turned 
out to be leaky as colonies resistant to both antibiotics did not result from transpo-
sition but from electroporation of both plasmids. In order to recover only transpo-
sition events another approach was undertaken introducing a different negative 
selection. A donor plasmid was cloned carrying an rpsL and sacB cassette, coding 
for streptomycin and sucrose sensitivity gene, respectively. Bacteria carrying this 
plasmid cannot grow in presence of streptomycin and 5% sucrose. Thus, to sur-
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vive on double-selection they have to carry a target plasmid with transposon se-
quence resulted from the transposition event. 
 
 
 
Abb. 11: In vitro transposition assay. Donor and target DNA are incubated together with 
purified transposase and after purification electroporated into bacteria and selected for 
transposition events. 
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Much effort has been previously undertaken to create an active purifiable SB-
fusion protein. None of the C-terminal fusions showed any activity suggesting that 
the SB transposase does not sustain a tag fused to its C-terminus. Therefore, all of 
the proteins used in the experiments are N-terminal SB-fusions. First, in the assay 
shown in Abb. 11 a maltose-binding protein-SB fusion was tried (MBP-SB). MBP 
is a large tag increasing the stability and solubility of the fused protein. Indeed, 
MBP-SB fusion was easy to purify (data not shown). A prerequisite for transposi-
tion is the DNA-binding activity of the protein that can be easily tested in an elec-
tromobility shift assay. Therefore, the purified MBP-SB fusion protein subjected 
to the in vitro assay was checked for its ability to bind the SB DNA. I performed 
an EMSA using left IR as a probe and observed two shifted bands. One is be-
lieved to be a protein monomer bound to one binding site and the slower migrat-
ing band could correspond to two transposase monomers bound to two binding 
sites present in the inverted repeat (IR) or a dimer formed on one binding site 
(Abb. 12A, lane 2 and 3). To solve the molecular composition of the complexes, 
two IRs were used each missing one of the binding sites (Abb. 12B). If a dimer 
forms on the DNA, two shifted bands would occur corresponding to a monomer 
and a dimer bound to the present binding site, respectively. However, with mu-
tated IRs only one band was observed (Abb. 12B) suggesting that the purified 
MBP-SB protein binds to DNA as a monomer and is not able to form dimers in
vitro. This can be due to improper folding of the transposase caused by the large 
MBP tag. The functionality of the protein must be disrupted as in the in vivo 
transposition assay no activity of the fusion transposase was proved. Transfection 
of the MBP-SB with neo-resistant transposon construct did not lead to a raise in 
G-418 resistant colony number in comparison to the negative control performed 
with catalytically inactive transposase. Lack of the in vivo activity of the MBP-SB 
fusion transposase can be the explanation for the failure of the in vitro trials. 
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Abb. 12: MBP is able to bind DNA but not to form dimers. A. demonstration of the 
DNA binding ability of the MBP-SB in EMSA (lane 2 and 3); B. MBP-SB forms single 
complexes with IRs lacking one binding site; - and + stand for without and with protein, 
respectively. 
 
In contrary, the His-tagged SB had activity in vivo, though, very low. The purified 
protein, on the other hand, was not stable as I observed degradation products (data 
not shown). Additionally, in binding assays only bands migrating as purified His-
tagged DNA-binding domain of the SB used as a control for the assay were pre-
sent indicating formation of complexes with shorter than full-length proteins (data 
not shown). As it seemed that the size of the tag may distort the proper folding of 
the transposase and this way inactivate it and fusion with short tag retained some 
activity, another small tag was fused to the transposase. STREP is an eight-residue 
peptide sequence that exhibits intrinsic affinity toward streptavidin. The expressed 
STREP-SB fusion protein (Abb. 13A, lane 2) goes into inclusion bodies, as after 
sonication no SB was detected in the supernatant fraction but a strong band corre-
sponding to the SB transposase was present in the pellet fraction (Abb. 13A, lane 
3 and 4, respectively). The complete insolubility of the fusion protein was the ob-
stacle in obtaining functional SB transposase. 
The chemical properties of the protein dramatically changed when between the 
STREP-tag and the SB a JAZZ linker was introduced. JAZZ is an artificial zinc 
finger protein binding to a 9-bp sequence in the promoter region of the human 
utrophin gene [Corbi N, 2000]. The idea of fusing the JAZZ linker to the SB trans-
posase comes from observations of my colleague. Her JAZZ-SB fusion was able 
to promote the transposition reaction in vivo. When the STREP was added for 
purification purposes the STREP-JAZZ-SB construct retained moderate activity in 
HeLa cells, estimated from three independent transposition assay experiments for 
approximately 20% of the wild-type transposase (data not shown). Therefore, the 
purified STREP-JAZZ-SB was subjected to the in vitro transposition assay 
(shown in Abb. 11). 
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Abb. 13: Purification of the SB fusion proteins. A. Coomassie staining of the purifica-
tions steps of the STREP-SB. On the gel fractions of the uninduced (1) and induced (2) 
E.coli, supernatant (3) and pellet (4) after sonication. M stands for the marker. B. Purified 
STREP-JAZZ-SB on the polyacrylamide gel stained with Coomassie. 
 
Conditions for the SB in vitro transposition were chosen based on published data 
on the in vitro systems of the related Tc1 and mariner transposons [Vos, 1996], 
[Lampe, 1996] and knowledge collected in our laboratory about Sleeping Beauty 
transposase and properties of the system. The basic buffer for the reaction was 
composed of 25 mM HEPES and 100 mM KCl supplied with 5 mM MgCl2 and 1 
mM DTT. Additionally, reactions were conducted in enriched buffers containing 
10 % glycerol, 10 % DMSO or 0.02 % NP40. The target and donor DNA plasmid 
were supplied in amounts of 2 g and 200 ng, respectively, and the purified 
STREP-JAZZ-SB at low concentration to avoid the overproduction inhibition 
effect. Purified HMGB1, shown to be the host factor of the transposition was also 
added to the reaction. Moreover, as no colonies growing on Amp+Zeo+Strep and 
sucrose selection were recovered, reactions with different protein-DNA ratios 
were performed to find optimal conditions for the transposition to take place. 
However, no transposition events were detected in the in vitro assays with the 
conditions applied. 
 
Approaches to obtain an active SB-fusion protein and properties and activities of 
the created fusions are summarized in Tab. 1. Unfortunately, none of the fusion 
proteins was successful and trials to establish the in vitro transposition assay 
failed. 
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 His-SB MBP-SB STREP-SB STREP-
JAZZ-SB 
HA-SB 
Solubility Very low  - good  
DNA binding Partially  nd good ? 
In vivo activity 15% - nd 20% 50% 
In vitro activity nd nd nd no activity ? 
Tab. 1: Properties and activities of the tagged SB transposases. In blue the activities 
and properties tested within the project. * only binding of the N-terminal domain to DNA 
could be detected. 
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6 DISCUSSION 
 
 
Transposons are mobile pieces of DNA widespread throughout all living organ-
isms. They can be grouped in families based on their structure and mechanism of 
transposition (Abb. 1). The transposition process is believed to be a multistep re-
action with several protein-DNA and protein-protein interactions that take place in 
a sequential manner. The reaction can be regulated at different steps by transpo-
son- and host-mediated mechanisms. Sleeping Beauty is a fish transposon recon-
structed from molecular fossils [Ivics, 1997] to restore a vertebrate transposable 
element for genetic applications. It is a member of Tc1/mariner family with a 
complex IR/DR structure of the transposon DNA. The IR/DR structure refers to 
inverted repeats (IR) each containing two direct repeats (DR) serving as binding 
sites for the transposase (Abb. 2B). The inverted repeat upstream of the gene is 
commonly called left IR and the inverted repeat downstream of the gene, right IR. 
The left IR contains additionally between the DRs an enhancer site. The binding 
sites are very similar but not identical, showing 3 nucleotides differences in se-
quence and 2 nucleotides differences in length. The complex IR/DR structure of 
SB, with its sequence, combination of the inter-DR spacing and geometry of the 
DRs, is very sensitive to changes as exchanging the inner DRs for the outer DRs 
or removing the sequence between the DRs strongly decreased the transposition 
efficiency [Cui, 2002], [Izsvak, 2002]. These observations indicate that the IR/DR 
structure is of high importance for the transposition reaction. Moreover, the results 
of experiments aiming to find sequences bound stronger by the transposase 
showed that increasing the strength of the transposase binding to the transposon 
DNA does not boost the overall transposition rate. Quite the contrary, enhancing 
one step of the reaction may negatively influence the following steps leading to 
decreased transposition efficiency. One explanation can be that the assembly of 
the four binding sites and transposase molecules is not a spontaneous, but a pre-
cisely arranged process. Altering the DNA binding affinities of the binding sites 
could perturb the strict order of the assembly process. 
In order to understand the function of the complex IRs of the SB, I compared the 
system to a transposon with simple IRs. The IR/DR structure of the Sleeping
Beauty transposon is not present in the mariner-like elements, a subfamily of the 
Tc1/mariner transposons. mariners have short IRs each containing one binding 
site for the transposase. Both systems were subjected to in vivo transposition assay 
using complete transposon sequences and constructs lacking the right IRs. Dimer 
of the Himar1 transposase was previously reported to show catalytic activities on 
one transposon end [Lipkow, 2004]. Similarly, many transposition events were 
recovered with single-end Hsmar1 transposon (Abb. 5A and B). Sleeping Beauty 
was also capable of single-end transposition but to much lower extent. During 
such transposition, the borders of the transposon are not precisely defined. While 
in SB transposition, the cleavage and transposition of the left IR is normal, the 
liberation of the other end of the transposon does not seem to be transposase-
mediated. In principle, the second DNA break can occur inside of the transposon 
 48
or, somewhere in the genome, contributing this way to genomic instability. Lower 
number of imprecise transposition events is a result of better regulation of the SB 
transposition that might be imposed by the IR/DR stucture. The complexity of the 
inverted repeats together with the bipartite (PAIRED) DNA-binding domain of SB 
might offer means for more sophisticated regulation of the transposition process, 
thereby protecting the genome from aberrant transposition events. 
 
 
6.1 Dissection of the paired-end complex formation 
 
I performed experiments to dissect the transposition process and to gain insight 
into single steps of the reaction. When the subdomains were separated and ana-
lyzed independently from each other, I could learn not only about their activities 
but the results allowed me to draw a model how the transposition complex is 
formed. 
PAI subdomain of the transposase specifically recognizes the binding substrate. 
The specificity of self-identification is high as SB is able to distinguish its own 
sequence from a related zebrafish binding site, differing only by 5 out of 17 bp in 
the PAI recognition motif [Ivics, 1997]. Incubating purified PAI and RED sub-
domains with oligonucleotides corresponding to each binding site and resolving in 
electrophoretic mobility shift assay (EMSA) revealed that the PAI binds stronger 
the inner binding site (Abb. 6A, lanes 3 and 6). Interestingly, the RED subdomain 
binds only the inner binding site. No binding of the RED to the outer binding site 
was detected (Abb. 6A, lanes 2 and 5). Results of the CAST-ing experiment sug-
gested that only the PAI subdomain is involved in the primary substarte binding, 
as only the PAI recognition motif of the DRs was present in the CAST-ing se-
lected oligonucleotides while the RED recognition motif was random. However, 
as the RED showed no recognition of the outer binding site it could suggest that 
the function of the RED subdomain in the primary binding would be to enhance 
the binding towards the inner binding site. It seems that the RED might be respon-
sible for determining the primary binding target, which is the inner binding site. 
Starting the complex formation from the inner binding site, distantly from the 
cleavage site, can be a manner to prevent enzymatic activities such as nicking and 
cleavage before the paired-end-complex (PEC) is formed. The RED binding is 
very specific and restricted to the inner binding site, as introducing two nucleo-
tides that are present in the outer binding site mimicking the longer binding site 
but leaving the rest of the sequence unmodified resulted in disruption of the bind-
ing (Abb. 6B, lanes 2 and 4). Additionally, I concluded from this EMSA experi-
ment that the RED subdomain formed a dimer on the binding site. As I never ob-
served a band corresponding with size to a RED monomer bound to the DNA it is 
possible that the protein subdomain binds in a dimeric form. For mariner transpo-
sases, dimers appear to be the form binding to the inverted repeats [Augé-
Gouillou, 2005]. On the other hand, Butler and colleagues argue that mariners 
might bind as monomers and then quickly recruit another monomer to form a very 
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stable dimer [Butler, 2006]. Their statement is supported by the observation of the 
Himar1 transposase mutant lacking the protein-protein interaction activity that 
was still able to bind the DNA. Similarly, it is highly probable that the monomer 
of RED subdomain binds to the direct repeat. Then, the binding initiates a con-
formational change what releases protein-protein interaction activity of the RED 
leading to dimer formation. It can not be excluded that the active form of the RED 
subdomain able to interact with DNA is a dimer; however, binding of the mono-
mer followed by dimerization can be supported by the fact that the full-length 
DNA-binding domain was reported to be in a monomeric state in solution and 
tetramerize in the presence of DNA [Izsvak, 2002]. 
Interestingly, even though the outer direct repeat was not recognized by the RED 
subdomain in binding assays, its sequence can not be freely changed suggesting 
its importance in transposition. Footprinting data have shown that RED subdo-
main binds the 5’-part of the DRs and PAI the 3’-part [Izsvak, 2002]. In case of 
the outer binding sites RED contacts regions of the inverted repeats close to the 
cleavage sites. Substituting the RED recognition motif of the outer binding site 
with the sequence of one of the oligonucleotides selected in the CAST-ing ex-
periment showing no significant similarities to the wild-type binding site resulted 
in decreased transposition efficiency (Abb. 7). As the transposition reaction con-
sists of successive protein-protein and protein-DNA interactions, the RED-outer 
DR interaction may have a function at later step of the process, e.g. in cleavage. 
mariner-like element, Himar1 transposase containes only one HTH motif placed 
in the C terminus of the DNA-binding domain. Mutagenesis of this region of the 
Himar1 DNA-binding domain lead to impairment of cleavage and strand transfer 
[Butler, 2006]. If there is analogy of the structural and functional organization of 
the DNA-binding domain of the mariner-like elements and Sleeping Beauty, the 
cleavage and insertion Himar1 mutants may support the possible role of the RED 
subdomain in the cleavage upon interaction with the 5’-part of the outer DRs. 
Thus, no interaction of the RED with the outer binding site at the early steps of 
the transposition process additionally counteracts cleavage before the proper PEC 
formation. 
Since dimers of the mariner transposase formed on a single transposon end show 
catalytic activities [Lipkow, 2004] I checked whether the dimer of the SB transpo-
sase bound to the inner binding site or bringing two inner binding sites together is 
able to cleave the DNA at the inner binding sites. In order to answer this question, 
a truncated transposon construct was subjected to in vivo excision assay. The left 
inverted repeat was unmodified as removal of one DR from the left IR results in 
abolishment of the transposition (Abb. 4, construct 1). In the right IR only the 
inner DR was present, followed by the TA to mimic the cleavage site. No excision 
product was detected in the PCR based in vivo excision assay (Abb. 10C, con-
struct T/in). These results suggest existence of a regulatory mechanism inhibiting 
cleavage at the inner binding site, within the transposon sequence. Thus, unlike 
the mariners in SB system, the catalytic steps are prevented before the PEC for-
mation. 
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6.2 Influence of host factor HMGB1 on PEC formation 
 
Sleeping Beauty is active in many cell lines of different organisms suggesting no 
requirements for species specific host factors [Izsvák, 2000]. Nevertheless, an 
affect of host factors cannot be excluded. Indeed, four host factors have been iden-
tified that influence the transposition of SB and other transposable elements 
[Zayed, 2003], [Izsvak, 2004], [Walisko, 2006]. Many DNA recombinational 
processes require beside the recombinase additional proteins altering the DNA 
conformation. The complex assembly of the Mu transpososome does not proceed 
in absence of HU protein bringing the binding sites of the Mu transposase to-
gether [Lavoie, 1993]. HMGB1 is a eukaryotic protein bending the DNA 
[Thomas, 2001] previously reported to enhance the SB binding towards the inner 
binding site and to conduce the bending of the DNA bringing the transposon ends 
in proximity [Zayed, 2003]. Even though, in my experiments oligonucleotides 
corresponding to the binding sites and not the full-length transposon DNA were 
used, the positive influence of the HMGB1 was observed. Presence of the 
HMGB1 lead to enhanced formation of the complex containing dimer of the RED 
subdomain binding two inner DRs (Abb. 9A, compare lanes 2-4 and 5-7). The 
mechanism of the enhancement is, however, not clear. The bending protein is not 
stably incorporated into the complex as no additional shifted band appeared upon 
incubation with HMGB1. Similar observations were collected with the full-length 
SB transposase (MBP-SB, [Zayed, 2003]; my data not shown). HMGB1 interac-
tion with the RED subdomain was shown in the chemical cross-linking experi-
ment (Abb. 9B lane 3). 
 
 
6.3 Model of PEC formation 
 
I propose that the IR/DR structure with its four transposase binding sites of di-
verse affinities for the transposase at single steps of the reaction evolved to ar-
range the formation of the synaptic complex, which is the prerequisite for the sub-
sequent catalytic steps of transposition to take place. 
Based on my results a model of the paired-end complex formation was developed 
(Abb. 14). In the overall transposition process of SB, the left IR might be pre-
ferred over the right one, since left IR mutant/deleted transposons are completely 
inactive for transposition, while transposition can proceed even in the lack of 
complete right IR (Abb. 4, constructs 2 and 4). Interestingly, the left IR can be 
duplicated without major disturbance of the transposition reaction [Izsvak, 2002]. 
The affinity of the transposase is higher towards the inner binding site due to the 
RED subdomain distinguishing between the inner and outer binding site. This 
phenomenon is additionally enhanced by the host factor HMGB1. Thus, the com-
plex formation starts at the inner DR located distantly from the cleavage site. The 
dimer of the protein formed on the left inner binding site is able to capture the 
second transposon end. Incorporation of the inner binding site from the right in-
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verted repeat results in PEC formation. Importantly, the inner binding site is resis-
tant for cleavage even if the canonical cleavage site (TA|CAGT) is artificially 
engineered nearby (Abb. 10). Accordingly, replacing the outer binding site by the 
inner binding site at the end of the transposon, even if the cleavage site is avail-
able, decreases transposition by 80% [Cui, 2002]. Thus, starting the PEC forma-
tion with the inner binding sites decreases the probability of  cleavage before the 
proper complex fromation. 
The order of binding and inclusion of the other two binding sites into the PEC is 
not known in detail, but the incorporation of the outer DRs takes place after the 
inner DRs are brought together. The protein-protein and the DNA-interaction in-
terfaces of PAI and RED are proposed to be utilized in an alternative manner at 
different steps of the assembly process. For example, the homo-dimerization of 
RED but not PAI could be detected at the early steps of PEC formation. The pro-
tein interaction interface of PAI is predicted to play a role at a later step of the 
complex assembly, perhaps in the process of positioning the IRs for cleavage. The 
IR/DR structure of SB seems to enforce PEC formation, and decrease the fre-
quency of imprecise transposition events. 
For some transposons, the complex formation has been studied very deeply and 
there is evidence that it is a multistep complex reaction. The paired-end-complex 
formation, where two transposon ends are brought in close proximity, is a prereq-
uisite for the catalytic activities of the bacterial Tn5 and Tn10 transposons as the 
transposases act in trans [Naumann, 2000]. It means that the transposase bound to 
one transposon end process the cleavage of the second transposon end Activity on 
a single end of the transposon is inhibited because the transposase is unable to 
dimerize in the absence of the second transposon end [Naumann, 2000]. Thus, if 
proper complex formation fails, no excision would take place. For all of classical 
bacterial transposons characterized to date, the catalytic steps of the reaction are 
tightly coupled to the synapsis of the transposon ends (PEC) [Savilahti, 1996]. 
Therefore, PEC formation serves an important regulatory checkpoint of the trans-
position process. 
In contrary, mariner-like element Himar1 was reported to form active complexes 
on one transposon end in vitro [Lipkow, 2004]. Thus, in mariners systems, PEC 
formation does not serve as an absolute checkpoint control to enforce the synapsis 
of the two ends of the transposon prior catalysis. Sleeping Beauty was also able to 
transpose with only one inverted repeat; however, with much lower efficiency 
than Hsmar1 (Abb. 5). The organization of the IRs, short with single binding sites 
for mariners and long IRs each containing two DRs of Sleeping Beauty, implies 
that different pathways are used by mariner- and Tc1-like elements to regulate 
transposition initiation and thus leading to the formation of differently organized 
synaptic complexes. My results indicate that the IR/DR structure of the SB trans-
poson introduces higher level of regulation of the transposition process. Four 
binding sites of different affinities and two DNA-binding subdomains serve addi-
tional regulation points for the ordered assembly process. “Ordered assembly” as 
a regulatory mechanism was already described in the context of V(D)J recombina-
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tion or bacteriophage Mu transposition. Such regulation is able to filter out unde-
sired or aberrant reaction intermediates. 
 
 
 
Abb. 14: Model of the paired-end-complex (PEC) formation. The blue and red ovals 
represent the PAI and the RED subdomain of the SB DNA-binding domain, respectively. 
A. The DNA-binding domain of the transposase is able to bind both binding sites but the 
affinity towards the inner binding site is enhanced. The formation of the complex starts at 
the inner DR. This step is enhanced by the HMGB1 (EMSA with the full-length SB; [Zayed, 
2003]). B. The next step is the dimerization of the SB transposase performed by the RED 
subdomain. C. The RED is then able to catch the second transposon end, which is the 
second inner binding site. This step is enhanced by the HMGB1 (here shown as orange 
ovals). D. Incorporation of two transposase monomers interacting with the outer binding 
sites accomplishes the PEC formation. The scissors imply that the complex is ready to 
undergo catalytic activities. 
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6.4 In vitro transposition assay 
 
The in vitro transposition assays have been developed for the mariner Mos1 [Tosi, 
2000] and Tc1 element [Vos, 1996], both having short inverted repeats. These 
transposons are able to mediate the reaction in simple conditions as long as the 
donor and target DNA, the transposase and the magnesium divalent ions for pro-
tein’s catalytic activities are supplied. The results from the Tc1 experiments indi-
cate possible stimulatory role of the host factors on the transposition reaction as 
the assay with the worm extract yielded significantly higher number of transposi-
tion events than the assay with Tc1 transposase purified from the E.coli. Never-
theless, transposase is the only protein required and the transposition can take 
place in suboptimal conditions. These conditions were applied for the Sleeping
Beauty in vitro transposition assay; however, with no positive result. The assay 
was modified based on our knowledge about the SB system collected until now to 
apply the probable preferred conditions. Those include low amounts of the trans-
posase as SB undergoes overproduction inhibition, meaning that high concentra-
tion of the protein leads to decrease of the transposition efficiency, and addition of 
the host factor HMGB1. Although different protein-DNA ratios were used no 
transposition event was detected. It can be due to the fusion proteins used in the 
experiments. Sleeping Beauty transposase does not tolerate tags on the C-terminus 
and the tags on the N-terminus significantly decrease the activity of the protein. 
Thus, it can not be excluded that the purified proteins did not exhibit all the re-
quired activities. However, the failure of the establishment of the in vitro transpo-
sition assay may result from the sophisticated regulation of the multistep reaction 
that will not proceed to the next step if the conditions are not fulfilled. 
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